The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Blood Cancer Journal
(Sep 2022)
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
Jarrod Longcor,
Natalie Callander,
Kate Oliver,
Asher Chanan-Khan,
Sikander Ailawadhi
Affiliations
Jarrod Longcor
Cellectar Biosciences, Inc.
Natalie Callander
University of Wisconsin Carbone Cancer Center
Kate Oliver
Cellectar Biosciences, Inc.
Asher Chanan-Khan
Division of Hematology-Oncology, Mayo Clinic
Sikander Ailawadhi
Division of Hematology-Oncology, Mayo Clinic
DOI
https://doi.org/10.1038/s41408-022-00725-2
Journal volume & issue
Vol. 12, no. 9
pp. 1 – 3
Abstract
Read online
No abstracts available.
WeChat QR code
Close
